NAURA Technology Group (002371) Report Interpretation

Overview

This earnings update assesses NAURA Technology Group’s Q2 2026 results and its progress in higher-end semiconductor equipment. UBS considers the revenue shortfall mainly a timing issue, while in-line profit, better operating margins and new-product/customer progress underpin its maintained Buy rating and Rmb800.00 target price.

Core views

NAURA reported Q2 revenue growth of 24% year on year but a 4.7% sequential decline; revenue was 9% below UBS expectations. UBS attributes this primarily to the timing of order revenue recognition rather than a deterioration in demand or full-year prospects. Q2 attributable net profit of Rmb1.735bn, up 6.6% year on year and 6.2% sequentially, was in line with UBS expectations. UBS notes that NAURA’s sequential revenue performance was weaker than the average 48% growth reported by AMEC, ACM and Piotech, but argues that the comparison reflects a high base: NAURA’s Q1 revenue decline was only 14% sequentially, versus a 32% average decline for those peers. With domestic semiconductor-equipment revenue recognition generally taking around 12 months, UBS believes the Q2 timing effect should have limited impact on the annual outlook. Its industry checks and leading indicators point to continued marginal improvement in downstream demand, supporting its forecast for full-year revenue growth of 32% year on year. Profitability improved despite a mix-related gross-margin decline. Q2 blended gross margin fell 1.5 percentage points sequentially to 39.3%, which UBS attributes to product-mix changes and commercial discounts for some major customers. However, the firm estimates that semiconductor-equipment gross margin remained above that of most domestic peers, given the higher margin profile of NAURA’s semiconductor-equipment business relative to its electronic industrial equipment business, whose H1 2026 gross margin was 39.75%. EBIT margin and recurring net profit margin rose 1.0 percentage point and 1.8 percentage points, respectively, from Q1, driven by stronger expense control. The report also emphasizes expanding product and customer coverage. NAURA increased shipments across etching, thin-film deposition and thermal-processing equipment, while penetration in advanced logic, advanced memory and power semiconductors continued to rise. In H1 2026, its high-end ICP etching tool—featuring angstrom-level etching uniformity and an aspect ratio of several hundred to one—completed customer validation and was being introduced into mass production. Its new-generation tube-type ALD tools were delivered in batches to domestic memory manufacturers; high-end TSV electroplating equipment reached scaled supply for advanced packaging and 3D integration; and immersion ion-implantation orders and deliveries grew steadily. UBS maintains its Key Call Buy and Rmb800.00 12-month price target. The target is based on 50x 2027E P/E, implying 1.4x PEG against UBS’s projected 35% 2027-29E EPS CAGR. At Rmb700.40 on 25 August 2026, UBS calculates 14.2% forecast price appreciation, 0.1% forecast dividend yield and 14.4% forecast stock return, compared with a 6.8% market-return assumption.

Analysis framework

UBS compares quarterly revenue and profit with its forecasts and domestic peers, then evaluates whether revenue timing changes the full-year demand outlook. It examines gross and operating-margin movements, product mix and expense control, and links equipment launches, customer validation, deliveries and market penetration to future growth. The valuation applies a 2027E P/E multiple and PEG comparison to derive the price target.

Methodology notes

• Valuation methodsP/E and PEG Valuation

  P/E and PEG valuation

  UBS values NAURA using a 50x 2027E P/E multiple; the resulting target implies 1.4x PEG based on a projected 35% 2027-29E EPS CAGR.

• Industry AnalysisVolume-price decomposition

  Revenue-recognition timing and quarterly growth comparison

  The report separates reported quarterly revenue from underlying demand, arguing that order-recognition timing and a higher Q1 base explain the sequential revenue decline.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• NAURA Technology Group (002371.SZ)

  Primary covered company; UBS links its growth outlook to domestic semiconductor-equipment demand, wider high-end product coverage and customer-end progress.

  Strengths

  Expanded shipments across etching, thin-film deposition and thermal processing; progress in advanced logic, memory, power semiconductors and advanced packaging.

  Weaknesses

  Q2 revenue was 9% below UBS expectations and blended gross margin fell 1.5 percentage points sequentially to 39.3%.

  Comparison

  Q2 sequential revenue decline of 4.7% lagged the 48% average growth of AMEC, ACM and Piotech, though UBS attributes this partly to NAURA’s stronger Q1 revenue base.

  Risks

  Geopolitical restrictions, weaker China WFE demand and stronger competition could pressure market share in etching, deposition and cleaning.

Key data

• Q2 revenue growth+24% YoY / -4.7% QoQRevenue was 9% below UBS expectations; UBS attributes the shortfall mainly to order-recognition timing.
• Q2 attributable net profitRmb1.735bn+6.6% YoY and +6.2% QoQ; in line with UBS expectations.
• Q2 blended gross margin39.3%Down 1.5 percentage points sequentially, mainly due to product mix and commercial discounts.
• Q2 EBIT margin and recurring net profit margin+1.0ppt / +1.8ppt QoQUBS attributes the improvements mainly to stronger expense control.
• Full-year revenue growth forecast+32% YoYUBS says demand indicators and industry checks support continued growth visibility.
• 2027-29E EPS CAGR35%Used in UBS’s PEG framing for the target valuation.
• Price target valuation50x 2027E P/E; 1.4x PEGBasis for the Rmb800.00 target price.

Impact & implications

UBS views the Q2 revenue miss as a quarterly recognition issue rather than a break in NAURA’s growth trajectory. It argues that improving operating margins and higher-end equipment commercialization can support growth as domestic semiconductor demand and customer adoption develop.

Risks

• Geopolitical tensions could intensify and restrictions could be extended.
• China WFE demand could be weaker than UBS expects.
• Competition could intensify and cause market-share losses in etching, deposition and cleaning.

What to watch

• Whether China’s memory-fab capital expenditure rises further over the next three months.
• Whether overseas peers raise product prices, potentially improving the domestic pricing and profitability environment.
• NAURA’s opportunities to expand into overseas fab customers.
• Customer validation, mass-production introduction and delivery progress for high-end etching, deposition, packaging and ion-implantation equipment.